Cid

ROME, February 8, 2011 - CID spa, a European company leader in interventional medicine, will present the key technologies implemented on CID's Cre8(TM) DES as well as all the new preclinical data at the Joint Interventional Meeting (JIM) during the Lunch Symposium "NEW DES: A NEW STEP FORWARD?" on Thursday, February 10, 2011.